Decreasing invasive pneumococcal disease in the elderly: A state-level analysis

Vaccine

Volumn 24, Issue 27-28, 2006, Pages 5609-5614

  McBean, A Marshall ^a   Jung, Kyoungrae ^a   Hebert, Paul L ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Invasive pneumococcal disease; Pneumonia vaccine

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

AGED; ARTICLE; DRUG CONJUGATION; GERIATRICS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICARE; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; VACCINATION;

AGED; AGED, 80 AND OVER; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; REGRESSION ANALYSIS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION;

EID: 33746791061     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.055     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR (2000) 49 #RR-9
2. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Eng J Med 348 (2003) 1737-1746
3. Lexau C., Lynfield R., Pilisivili T., Facklam R., Farley M.M., Harrison L.H., et al. Changes in the epidemiology of invasive pneumococcal disease among older adults: evidence for indirect effects of pediatric pneumococcal conjugate vaccine presented at ICEID 2004. International Conference on Emerging Infectious Diseases. February 29-March 3, Atlanta, GA (2004)
4. Flannery B., Schrag S., Bennett N.M., Lynfield R., Harrison L.H., Reingold A., et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 291 (2004) 2197-2203
5. C.D.C. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR 54 (2005) 893-897
6. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., et al. Changing epidemiology of invasive pneumococcal disease among older adults in an era of pediatric pneumococcal conjugate vaccine. JAMA 294 (2005) 1043-1051
7. McBean A.M., Park Y.-T., and Caldwell D. Declining invasive pneumococcal disease in the U.S. Elderly. Vaccine 23 (2005) 5641-5645
8. O'Brien K.L., and Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 21 (2003) 1815-1825
9. CDC. National Immunization Survey available at http://www.cdc.gov/nis/; last accessed February 20, 2006.
10. CDC. Behavioral Risk Factor Surveillance System available at http://apps.nccd.cdc.gov/brfss/; last accessed November 7, 2005.
11. Talbot T.R., Poehling K.A., Hartert T.V., Arbogast P.G., Halasa N.B., Edwards K.M., et al. Seasonality of invasive pneumococcal disease: temporal relationship to documented influenza and respiratory syncytial viral circulation. Am J Med 118 (2005) 285-291
12. Shapiro E.D., and Clemens J.D. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk for serious pneumococcal infections. Ann Int Med 101 (1984) 325-330
13. Shapiro E.D., Berg A.T., Austrian R., Schroeder D., Parcells V., Margolis A., et al. The protective efficacy of pneumococcal polysaccharide vaccine. N Engl J Med 325 (1991) 1453-1460
14. Farr B.M., Johnson B.L., Cobb D.K., Fisch M.J., Germanson T.P., Adal K.A., et al. Preventing pneumococcal bacterimia in patients at risk: results of a matched case-control study. Arch Int Med 155 (1995) 2336-2340
15. Jackson L.A., Neuzil K.M., Yu O., Benson P., Barlow W.E., Adams A.L., et al. Vaccine safely datalink. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 348 (2003) 1747-1755
16. Melegaro A., and Edmunds J. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol 19 (2004) 353-363
17. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safely and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
18. Centers for Disease Control and Prevention. Limited supply of pneumococcal conjugate vaccine. MMWR 52 (2003) 1234
19. Centers for Disease Control and Prevention. Updated recommendation on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR 53 (2003) 177-1778
20. Last J.M. A dictionary of epidemiology. 3rd ed. (1995), Oxford University Press, New York, NY
21. Szklo M., and Nieto F.J. Epidemiology: beyond the basics (2000), Aspen Publishers, Inc., Gaithersburg, MD